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Abstract In response to epidermal injury, Parasilurus asotus, a
catfish, secreted a strong antimicrobial peptide into the epithelial
mucosal layer. The molecular mass of the antimicrobial peptide,
named parasin I, was 2000.4 Da, as determined by matrix-
associated laser desorption ionization mass spectrometry. The
complete amino acid sequence of parasin I, which was determined
by automated Edman degradation, was Lys-Gly-Arg-Gly-Lys-
Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser.
Eighteen of the 19 residues in parasin I were identical to the N-
terminal of buforin I, a 39-residue antimicrobial peptide derived
from the N-terminal of toad histone H2A [Kim et al. (1996)
Biochem. Biophys. Res. Commun. 229, 381^387], which implies
that parasin I was cleaved off from the N-terminal of catfish
histone H2A. Parasin I showed strong antimicrobial activity,
about 12^100 times more potent than magainin 2, against a wide
spectrum of microorganisms, without any hemolytic activity.
Circular dichroism spectra of parasin I indicated a structural
content of 11% K-helix, 33% L-sheet, and 56% random coils. The
L-sheet axial projection diagram of parasin I showed an
amphipathic structure. Our results indicate that the catfish
may produce parasin I from its histone H2A by a specific
protease upon injury to protect against invasion by microorgan-
isms.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
Antimicrobial peptides, which are widespread in nature and
are among the earliest developed elements of innate immunity,
are important components of the natural defenses of living
organisms against invading microorganisms [1,2]. Many dif-
ferent kinds of antimicrobial peptides have been found from
amphibians [3], insects [4], mammals [5], plants [6], microor-
ganisms [7,8], and ¢shes [9,10]. Most of the antimicrobial
peptides kill target cells rapidly and speci¢cally, and have
unusually broad activity spectra [9,11]. In addition to the
microbicidal activity, antimicrobial peptides may also have
other functions such as promotion of wound healing [12],
stimulation of monocyte chemotaxis [13], and inhibition of
cytokine response [14].
Mucous surfaces of living organisms are under constant
attack from microorganisms. However, invasive infections
are rare, remain localized, and heal rapidly. Recent reports
have established antimicrobial peptides as the host-defense
e¡ector molecules which protect the mucous epithelia from
invading microbes [15]. Some of these agents of mucosal im-
munity include andropin from the ductal epithelial cells of the
reproductive tract of Drosophila [16], magainins from the mu-
cosal skin surface and the gastrointestinal tract of Xenopus
laevis [17], buforin I from Bufo bufo gagarizans [11], tracheal
antimicrobial peptide (TAP) from the bovine tracheal mucosa
[18], and pleurocidin from Pleuronectes americanus [19].
Even though many antimicrobial peptides have been re-
ported in the mucous layer of amphibians, insects, and mam-
mals [11,16,18], only a few have been found in the mucous
layer of aquatic organisms [9,10,22]. In this study, we report
the discovery of a strong and inducible antimicrobial peptide
from the epithelial mucosal layer of the cat¢sh, Parasilurus
asotus.
2. Materials and methods
2.1. Microorganisms
All of the microorganisms used in this study were obtained from the
American Type Culture Collection (ATCC). The following microor-
ganisms were used: Bacillus subtilis ATCC 62037, Staphylococcus au-
reus ATCC 15752, Streptococcus mutans ATCC 25175, Pseudomonas
putida ATCC 17426, Escherichia coli ATCC 27325, Salmonella typhi-
murium ATCC 15277, Serratia sp. ATCC 21074, Cryptococcus neo-
formans ATCC 34881, Saccharomyces cerevisiae ATCC 44774, and
Candida albicans ATCC 10231.
2.2. Peptide puri¢cation
Cat¢shes were injured by scratching the skin (16 cm2) with a sand-
paper and 5 h after the wounding, the cat¢shes were stunned by
electro-shock. The proteinaceous epithelial mucosal layer was scraped
o¡ from both the unwounded and wounded cat¢shes. The mucus
(20 g) collected from the cat¢sh skin was then homogenized using a
Waring blender (Waring, New Hartford, CT, USA) in 200 ml of
extraction medium (0.2 M sodium acetate, 0.2% Triton X-100, and
1 mM phenylmethylsulfonyl £uoride). The homogenate was centri-
fuged at 20 000Ug for 30 min in a Himac SCR20BR (Hitachi, Tokyo,
Japan) and the supernatant was collected. The peptides in the super-
natant were subsequently subjected to reverse-phase concentration
using a Sep-Pak C18 cartridge (Millipore, Milford, MA, USA) which
was activated with 80% acetonitrile containing 0.1% (v/v) tri£uoro-
acetic acid (TFA) (bu¡er A) and £ushed with 0.1% (v/v) TFA (bu¡er
B) to remove the excess acetonitrile. After being loaded with the
supernatant, the Sep-Pak C18 cartridge was washed with 20 ml of
bu¡er B and the peptides trapped in the cartridge were eluted with
6 ml of bu¡er A. The eluate was then lyophilized and subsequently
resuspended in bu¡er B. The resuspended sample was applied to a
C18 reverse-phase high-performance liquid chromatography (HPLC)
column (3.9U300 mm, Delta Pak, Millipore) and elution was
achieved with a linear gradient of 0^80% acetonitrile in 0.1% TFA
for 2 h at a £ow rate of 1 ml/min. Each fraction was lyophilized,
resuspended in water, and was assayed for antimicrobial activity
against B. subtilis ATCC 62037. The peaks with antimicrobial activity
were identi¢ed and pooled. The purity of the isolated peptide was
assessed by reverse-phase HPLC and matrix-associated laser desorp-
tion ionization mass spectroscopy (MALDI-MS) (Kratos Kompact
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MALDI, Manchester, UK). The amount of the isolated peptide was
determined by amino acid analysis as described by Park et al. [9].
2.3. Antimicrobial and hemolytic activity assay
Antimicrobial activity of the samples was determined during each
puri¢cation step by the radial di¡usion assay using B. subtilis ATCC
62037 as described by Lehrer et al. [20]. A 20 ml culture of B. subtilis
ATCC 62037 cells in mid-logarithmic phase was washed with cold
10 mM sodium phosphate bu¡er (NaPB), pH 7.4, and resuspended
in 10 ml of cold NaPB. A cell suspension containing 1U106 bacterial
colony forming units (CFUs) was added to 6 ml of underlayer agar
(10 mM sodium phosphate, 1% (v/v) trypticase soy broth (TSB), 1%
(w/v) agarose, pH 6.5) and the mixture was poured into a Petri dish.
5 Wl samples were added directly to the 3-mm wells which were made
on the solidi¢ed underlayer agar. After incubation for 3 h at 37‡C, the
underlayer agar was covered with a nutrient-rich top agar overlay (6%
(w/v) TSB, 1% (w/v) agarose) and incubated overnight at 37‡C. Anti-
microbial activity was determined by observing the zone of suppres-
sion of bacterial growth around the 3-mm wells. The minimal inhib-
itory concentrations (MICs) of the isolated peptide against the
microorganisms were determined as described by Moore et al. [21].
100 Wl microorganism suspensions (105 CFU/ml) in 3% (w/v) TSB was
mixed with serial two-fold dilutions of the isolated peptide in a steri-
lized 96-well microtiter plate (Nunc F96 microtiter plates, Denmark).
The ¢nal concentration of the peptide ranged over 0.5^200 Wg/ml. The
96-well plate was incubated overnight at 37‡C and the inhibition of
growth was determined by measuring the absorbance at 620 nm on a
Model 550 Microplate Reader (Bio-Rad, Hercules, CA, USA). MIC
was de¢ned as the lowest concentration of peptide that inhibited
growth. Hemolytic activity of the antimicrobial peptide was assayed
as described by Park et al. [9].
2.4. Molecular mass determination and amino acid sequence analysis
Molecular mass of the antimicrobial peptide was determined by
MALDI-MS. Approximately 20 nmol of the lyophilized peptide was
dissolved in 50% acetonitrile containing 7% (w/v) sinapinic acid and
mixed with a Pt probe. After removing the solvent in warm air, the
peptide, adsorbed to the Pt probe, was applied to a vacuum chamber
and analyzed. Amino acid sequencing was performed by the auto-
mated Edman degradation method on an Applied Biosystems gas
phase sequencer, Model 477A (Foster City, CA, USA). Amino acid
sequence homology searches were performed by computerized query
of the GenBank/EMBL Data Bank. The antimicrobial peptide, whose
complete amino acid sequence was con¢rmed by amino acid analysis,
was synthesized at the Korea Basic Research Institute (Seoul, Korea)
to compare the antimicrobial activity between the isolated and syn-
thetic peptide.
2.5. Circular dichroism
For circular dichroism (CD) analysis, peptide samples were dis-
solved in either 50 mM NaPB or 50% (v/v) tri£uoroethanol (TFE)
in 50 mM NaPB. The CD spectra were recorded at room temperature
on a Jasco model J-715 spectropolarimeter (Jasco, Tokyo, Japan) with
a cell path length of 1 mm. Five scans per sample were performed and
averaged over the wavelength range 200^250 nm [22]. Ellipticity was
reported as mean residue ellipticity [a] (degrees cm2 dmol31). The
contents of K-helix, L-sheet and random coils were estimated as de-
scribed by Green¢eld and Fasman [23].
3. Results
3.1. Peptide puri¢cation
The mucosal layer was scraped o¡ from the wounded and
unwounded cat¢shes as described in Section 2 and immedi-
ately homogenized in the extraction media. The crude extracts
were centrifuged and the supernatants were subsequently con-
centrated by solid phase extraction on Sep-Pak C18 car-
tridges. The reverse-phase HPLC analysis of the wounded
cat¢sh extract showed the presence of several peaks which
were not present in that of the unwounded cat¢sh (Fig.
1A,B). This experiment was repeated several times with the
same results. Peaks a, b, and c in Fig. 1B were individually
collected and assayed for antimicrobial activity. Of the three
induced peaks, only peaks a and c showed antimicrobial ac-
tivity. Antimicrobial activity assay revealed that peak a
showed over 200 times stronger antimicrobial activity than
peak c. Therefore, only peak a, which showed the strongest
antimicrobial activity, was puri¢ed to homogeneity using C18
reverse-phase HPLC and fully characterized. Peaks b and c,
which did not show signi¢cant antimicrobial activity, were not
further characterized except for the molecular mass. The pu-
rity of the antimicrobial peptide in peak a was con¢rmed to be
over 95% homogeneous by reverse-phase HPLC (Fig. 1B, in-
set) and MALDI-MS (data not shown). The total amount
of the puri¢ed antimicrobial peptide recovered was about
0.1 Wg/g mucus. The puri¢ed antimicrobial peptide, named
parasin I (derived from the genus name of the cat¢sh, Para-
silurus), was used for further chemical and biological analyses.
3.2. Antimicrobial and hemolytic activity
The antimicrobial activity of parasin I was tested against 10
di¡erent microorganisms, including Gram-negative and
Gram-positive bacteria and fungi. The MICs (Table 1) indi-
cate that parasin I was approximately 12^100 times more
potent than magainin 2, which was puri¢ed from Xenopus
laevis [17], and up to 8 times more potent than buforin I, a
potent antimicrobial peptide which was isolated from Bufo
bufo gagarizans [11]. The antimicrobial activity of the syn-
thetic parasin I, which was synthesized by the solid-phase
synthesis method and quantitated by amino acid analysis,
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Table 1
Minimal inhibitory concentrations of parasin I, buforin I and magainin 2
Microorganism Minimal inhibitory concentration (Wg/ml)
Parasin I Buforin I Magainin 2
Gram-positive
Bacillus subtilis ATCC 62037 1 4 50
Staphylococcus aureus ATCC 15752 2 4 50
Streptococcus mutans ATCC 25175 1 8 100
Pseudomonas putida ATCC 17426 2 4 50
Gram-negative
Escherichia coli ATCC 27325 1 8 100
Salmonella typhimurium ATCC 15277 2 4 25
Serratia sp. ATCC 21074 4 8 50
Fungi
Cryptococcus neoformans ATCC 34881 2 4 12
Saccharomyces cerevisiae ATCC 44774 2 4 25
Candida albicans ATCC 10231 1 4 25
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was found to be identical to that of natural parasin I. Fur-
thermore, when tested against human erythrocytes, parasin I
(200 Wg/ml) caused only 0.2% hemolysis whereas melittin, a
hemolytic peptide [24], e¡ected 99.2% hemolysis at the same
concentration.
3.3. Molecular mass and amino acid sequence analysis
The molecular mass of parasin I was 2000.4 Da as deter-
mined by MALDI-MS (data not shown). Amino acid se-
quence analysis revealed that parasin I consisted of 19 resi-
dues, including three arginines and ¢ve lysines, which
contributed to the net charge of +8 (Fig. 2). The complete
amino acid sequence of parasin I was Lys-Gly-Arg-Gly-Lys-
Gln-Gly-Gly-Lys-Val-Arg-Ala-Lys-Ala-Lys-Thr-Arg-Ser-Ser.
The molecular mass of parasin I obtained by MALDI-MS
was in good agreement with the mass calculated from the
amino acid sequence. This result indicates that post-transla-
tional modi¢cations were not present in parasin I. Amino acid
sequence homology search showed that parasin I was highly
homologous to the N-terminal region of histone H2A, a rep-
lication-dependent protein (Fig. 2). Parasin I was identical to
the N-terminal of buforin I [11] in 18 of the 19 residues, which
corresponds to 95% homology. Parasin I also shared 89%
homology with the N-terminal of human histone H2A.5
[25]. The molecular mass of the two peptides in peaks b and
c (Fig. 1B) was 4203 and 3937 Da, respectively (data not
shown). However, these two peptides were not further studied
because of their poor antimicrobial activity.
3.4. Circular dichroism
The secondary structure of parasin I was estimated using a
spectropolarimeter in the absence and presence of TFE (Fig.
3A). The CD spectra were baseline-corrected and smoothed
by the algorithm provided by the manufacturer. When ana-
lyzed by the method of Green¢eld and Fasman [23], the CD
spectrum of parasin I in 50 mM NaPB indicated that the
contents of K-helix, L-sheet, and random coils were 11%,
33%, and 56%, respectively. Under the hydrophobic condition
of 50% TFE solution, the contents of K-helix, L-sheet, and
random coils changed to 0%, 37%, and 63%, respectively.
4. Discussion
The present study describes the isolation and characteriza-
tion of a potent antimicrobial peptide, parasin I, from the
mucous layer of the wounded cat¢sh skin, which is one of
the ¢rst reports of an inducible antimicrobial peptide in ¢sh.
Parasin I has a molecular mass of 2000.4 Da and consists of
19 amino acids, including three arginines and ¢ve lysines,
which contribute to the net charge of +8. Parasin I was found
only in the skin mucous extracts of the injured cat¢sh and not
in the uninjured cat¢sh (Fig. 1). The detection of parasin I
only in the wounded cat¢sh skin indicated that injuring the
cat¢sh skin stimulated the production or secretion of parasin I
into the mucous layer. When threatened or injured, cat¢sh
secretes a thick gel-like layer of proteinaceous materials,
which includes antibodies and lysozyme [26,27], to its skin
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Fig. 2. Amino acid sequence of parasin I. The sequence of parasin I, obtained by automated Edman degradation, is aligned with those of
buforin I and human histone H2A.5. The conserved residues are boxed.
Fig. 1. Reverse-phase HPLC analyses of extracts of unwounded (A)
and wounded Parasilurus asotus (B). The samples were loaded on a
3.9U300 mm Delta Pak C18 column and elution was achieved with
a linear gradient (dotted line) of acetonitrile in aqueous tri£uoroace-
tic acid (80% acetonitrile/0.1% TFA). Absorbance was monitored at
214 nm (solid line). Peaks a, b, and c indicate the absorption peaks
that were detectable only in the extract of injured cat¢sh and the
elution position of the isolated antimicrobial peptide is indicated by
peak a. The inset in B represents the HPLC pro¢le of the puri¢ed
peptide with a slow gradient.
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surface mainly from the unicellular glands of the epidermis
[28]. It is also known that amphibians, such as X. laevis,
Bombina sp., and Phyllomedusa sp., produce and store anti-
microbial peptides in the granular glands and release their
contents onto the epithelia upon adrenergic stimulation or
injury [29]. A similar secretory immune system may also be
responsible for the release of the antimicrobial peptide parasin
I in the cat¢sh skin. The other peptides (Fig. 1B, peaks b and
c), which did not show signi¢cant antimicrobial activity, may
have other functions related to epidermal injury.
The very high homology between parasin I and the N-ter-
minal region of histone H2A, the replication dependent pro-
tein, suggests that parasin I might be cleaved o¡ from the
N-terminal of cat¢sh histone H2A by a speci¢c protease cleav-
age. Production of antimicrobial peptides from the larger pep-
tides or proteins with other known functions by processing or
alternative splicing has been reported [1,11,30^32]. This group
of antimicrobial peptides include buforin I [11], GIP(7^42),
DBI(32^86) [30], XPF, CPF [31], and lactoferricin [32]. Bufor-
in I is a 39-amino acid antimicrobial peptide produced from
the N-terminal of histone H2A in the toad stomach by a
speci¢c proteolytic cleavage [33]. XPF is believed to be pro-
duced by an initial cleavage of the xenopsin precursor by a
‘trypsin-like’ enzyme and the subsequent removal of the
C-terminal arginine residue by a ‘carboxypeptidase B-like’ en-
zyme [31]. Recently, Fiorucci et al. [34] reported that tryptase,
an inducible trypsin-like serine proteinase from the mast cell
granules, has a preferential cleavage site in the histone H2A
molecule at a monobasic site, 20 residues downstream of the
N-terminus. Interestingly, the N-terminal fragment that is
produced from this hydrolysis corresponds to the parasin I
molecule with an additional arginine residue at the C-termi-
nus. It remains to be studied whether a series of enzymatic
cleavages is involved in the production of parasin I from
histone H2A.
Parasin I showed a strong antimicrobial activity towards
Gram-negative bacteria, Gram-positive bacteria, and fungi
without any hemolytic activity (Table 1). The MICs of parasin
I were in the range of 1^4 Wg/ml. The most potent antimicro-
bial peptides have been reported to kill susceptible bacteria in
vitro at concentrations in the range of 0.25^4 Wg/ml [35],
which indicates that parasin I is one of the most potent anti-
microbial peptides found so far. The antimicrobial property of
most antimicrobial peptides is generally attributed to their
amphipathic secondary structures with a net positive charge
[36]. The secondary structure of parasin I was investigated to
see if it formed, like many antimicrobial peptides, an amphi-
pathic structure. The CD spectra of parasin I in 50 mM NaPB
revealed a structural content of 11% K-helix, 33% L-sheet, and
56% random coils. The addition of TFE, an K-helix inducing
solvent, slightly increased the L-sheet content (37%) in parasin
I (Fig. 3A). This result suggests that parasin I formed a L-
strand, in both hydrophilic and hydrophobic environments,
instead of the linear amphipathic K-helix which is common
for many other antimicrobial peptides. An axial projection
diagram of parasin I was drawn with 170‡ rotation per residue
to determine whether it was possible for parasin I to form an
amphipathic L-strand (Fig. 3B). The axial projection of para-
sin I formed a nearly perfect amphipathic L-strand with seven
of the eight cationic residues on the hydrophilic side of the
L-sheet plane. Our results in this study indicate that cat¢sh
produce a strong antimicrobial peptide from histone H2A in
the epithelial mucosal layer upon epidermal injury to protect
against the invasion of microorganisms. Further works on the
identi¢cation of the protease responsible for cleaving parasin I
o¡ from histone H2A and the determination of the molecular
mechanism of antimicrobial action of parasin I are in prog-
ress.
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